Annual Cash & Cash Equivalents
$85.21 M
-$14.47 M-14.52%
December 31, 2024
Summary
- As of February 26, 2025, WGS annual cash & cash equivalents is $85.21 million, with the most recent change of -$14.47 million (-14.52%) on December 31, 2024.
- During the last 3 years, WGS annual cash & cash equivalents has fallen by -$315.36 million (-78.73%).
- WGS annual cash & cash equivalents is now -78.73% below its all-time high of $400.57 million, reached on December 31, 2021.
Performance
WGS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$85.21 M
+$27.32 M+47.19%
December 31, 2024
Summary
- As of February 26, 2025, WGS quarterly cash and cash equivalents is $85.21 million, with the most recent change of +$27.32 million (+47.19%) on December 31, 2024.
- Over the past year, WGS quarterly cash and cash equivalents has dropped by -$14.47 million (-14.52%).
- WGS quarterly cash and cash equivalents is now -81.53% below its all-time high of $461.28 million, reached on September 1, 2021.
Performance
WGS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WGS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.5% | -14.5% |
| 3 y3 years | -78.7% | -14.5% |
| 5 y5 years | - | -14.5% |
WGS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.7% | at low | -78.7% | +52.0% |
| 5 y | 5-year | -78.7% | at low | -81.5% | +52.0% |
| alltime | all time | -78.7% | at low | -81.5% | +52.0% |
GeneDx Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $85.21 M(-14.5%) | $85.21 M(+47.2%) |
| Sep 2024 | - | $57.89 M(+3.2%) |
| Jun 2024 | - | $56.08 M(-33.0%) |
| Mar 2024 | - | $83.67 M(-16.1%) |
| Dec 2023 | $99.68 M(-19.6%) | $99.68 M(+14.1%) |
| Sep 2023 | - | $87.39 M(-44.2%) |
| Jun 2023 | - | $156.66 M(-22.4%) |
| Mar 2023 | - | $201.90 M(+62.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $123.93 M(-69.1%) | $123.93 M(-35.2%) |
| Sep 2022 | - | $191.36 M(-32.8%) |
| Jun 2022 | - | $284.65 M(-9.6%) |
| Mar 2022 | - | $315.00 M(-21.4%) |
| Dec 2021 | $400.57 M(+270.4%) | - |
| Dec 2021 | - | $400.57 M(-13.2%) |
| Sep 2021 | - | $461.28 M(+326.6%) |
| Dec 2020 | $108.13 M | $108.13 M |
FAQ
- What is GeneDx Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GeneDx Holdings?
- What is GeneDx Holdings annual cash & cash equivalents year-on-year change?
- What is GeneDx Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GeneDx Holdings?
- What is GeneDx Holdings quarterly cash and cash equivalents year-on-year change?
What is GeneDx Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of WGS is $85.21 M
What is the all time high annual cash & cash equivalents for GeneDx Holdings?
GeneDx Holdings all-time high annual cash & cash equivalents is $400.57 M
What is GeneDx Holdings annual cash & cash equivalents year-on-year change?
Over the past year, WGS annual cash & cash equivalents has changed by -$14.47 M (-14.52%)
What is GeneDx Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of WGS is $85.21 M
What is the all time high quarterly cash and cash equivalents for GeneDx Holdings?
GeneDx Holdings all-time high quarterly cash and cash equivalents is $461.28 M
What is GeneDx Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, WGS quarterly cash and cash equivalents has changed by -$14.47 M (-14.52%)